The largest database of trusted experimental protocols

Lenti x tet on advanced inducible expression system

Manufactured by Takara Bio
Sourced in United States

The Lenti-X Tet-On Advanced Inducible Expression System is a tool for controlling gene expression in mammalian cells. It utilizes a tetracycline-inducible gene expression system to provide tight regulation of target gene expression. The system consists of a Tet-On Advanced Transactivator Protein and a Tet response element to drive expression of the gene of interest.

Automatically generated - may contain errors

17 protocols using lenti x tet on advanced inducible expression system

1

Tet-Inducible TUSC2 Expression System

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tet-inducible TUSC2 expressing cells were produced using Lenti-X Tet-On advanced inducible expression system (Clontech, Mountain View, CA) according to the manufacturer’s instructions. Briefly, H1299, and H157 cells were infected with lentivirus generated with the pLVX-Tet-On advanced vector to constitutively express the tetracycline-controlled transactivator. After G418 selection, surviving colonies were expanded and infected with pLVX-Tight-Puro-Luc. New colonies were selected and expanded under G418 and puromycin. Surviving clones were selected after exposure to 2 μg/ml doxycycline for 48 hours, and assessed for TUSC2 expression by Western blotting.
+ Open protocol
+ Expand
2

Inducible PROX1 and DBC1 Expression in SW480 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SW480 cells inducibly expressing PROX1 were generated using Lenti-X Tet-On Advanced Inducible Expression System (Clontech, Moutain View, CA, USA). Briefly, SW480 DBC1 KO cells were infected with lentiviruses expressing reverse-Tet-controlled transactivator (rtTA-Advanced). Selected G418-resistant clones (SW480 DBC1 KO/rtTA) were analyzed for doxycycline inducibility using pLVX-Tight-Puro-LUC. SW480 DBC1 KO/rtTA cells were then transduced with lentiviral particles packaged with pLVX-Tight-Puro-PROX1 and pLVX-Tight-Puro-DBC1. Selected G418/puromycin-resistant cells (SW480 DBC1 KO/rtTA-PROX1 or SW480 DBC1 KO/rtTA-PROX1-DBC1) were analyzed for DBC1 or PROX1 expression by immunoblot and qRT–PCR with and without doxycycline induction.
+ Open protocol
+ Expand
3

Tet-Inducible TUSC2 Expression System

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tet-inducible TUSC2 expressing cells were made using Lenti-X Tet-On advanced inducible expression system (Clontech) according to the manufacturer’s instructions. Clones were maintained in RPMI-1640 medium, supplemented with 10% Tet-free heat-inactivated fetal bovine serum (Clontech). Briefly, A549, H1299, and H157 cells were infected with lentivirus generated with the pLVX-Tet-On advanced vector to constitutively express the tetracycline-controlled transactivator. After G418 selection, surviving colonies were expanded and infected with pLVX-Tight-Puro-Luc. New colonies were selected and expanded under G418 and puromycin. Best functional transactivators were selected after exposing cells to 2μg/ml of doxycycline for 48 hrs. Luciferase activity in cell extracts was assessed using Promega Luciferase Assay (Promega). Clones were assessed for TUSC2 expression induction by Western blotting.
+ Open protocol
+ Expand
4

Inducible overexpression of RBM10 in A549 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inducible overexpression of RBM10-EGFP wild type (WT) or mutants (MUTs) in A549 cells was achieved using the Lenti-X Tet-On Advanced Inducible Expression System (Clontech) according to the manufacturer’s manual. Briefly, lentiviral plasmids (pLVX-tight-puro) carrying RBM10-EGFP WT or MUTs or TetR (pLVX-Tet-On) were transfected into HEK293-FT cells together with three packaging plasmids (pLP1, pLP2, and pLP/VSVG, Invitrogen). Medium containing the lentiviral particles was harvested 48 or 72 hrs after transfection.
Lentiviral particles carrying TetR was added into the A549 cell cultures and selected by 200 μg/ml G418 (Invitrogen). The G418 selected cells were transfected with lentiviruses carrying RBM10 WT or MUTs followed by selection in medium containing 2 μg/ml puromycin (Sigma). Stably transfected A549 cells were maintained under standard conditions and overexpression of RBM10-EGFP proteins were induced by 1 μg/ml doxycycline treatment (Sigma) for 2 days unless otherwise stated.
+ Open protocol
+ Expand
5

Inducible Expression of E-cadherin and β-catenin in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable E‐cadherin‐Tet‐On and vector‐Tet‐On hESCs were generated from H9 and H1 hESCs as reported previously 28. Stable EcadΔβ‐Tet‐On and βS33Y‐Tet‐On hESCs were generated using Lenti‐X Tet‐On advanced inducible expression system (Clontech, Mountain View, CA, http://www.clontech.com) according to the manufacturer's instructions 28. EcadΔβ and βS33Y genes were amplified by PCR from hEcadΔβ‐pcDNA3 and pcDNA3‐βS33Y Beta‐catenin, respectively. The amplified fragments were cloned into pLVX‐Tight‐Puro vector and verified by DNA sequencing (see Supporting Information for details). Stable transduced hESC colonies were selected and maintained as previously described 28. To upregulate E‐cadherin expression, the selected colonies were treated with 1 μg/ml of doxycycline. To express βS33Y and EcadΔβ, the hESCs were treated with 2 μg/ml of doxycycline unless otherwise specified.
+ Open protocol
+ Expand
6

Inducible Lentiviral Expression of EPRS1 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flag-EPRS1 WT, F1097A, R1152L were subcloned to pLVX-TetOne™-Puro vector (Clontech, 631849). Lentiviruses were produced by Lenti-X 293 T cells (Clontech, 632180) using Lenti-X Tet-On advanced inducible expression system (Clontech, 632162) following the manufacturer’s instructions. Viruses in supernatant of Lenti-X 293 T were collected 48 h after transfection. Then, LX-2 cells were infected with the lentiviral supernatants in the presence of 8 μg/mL of polybrene. After incubated with the supernatant for 24 h, the infected cells were selected using puromycin (1 μg/mL) for 2 weeks. To induce protein expression, cells were incubated in the presence of doxycycline (2 μg/mL) for 96 h.
+ Open protocol
+ Expand
7

Inducible TUSC2 Expression in Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tet-inducible TUSC2-expressing H1299 and H157 cells were produced using the Lenti-X Tet-On advanced inducible expression system (Clontech, Mountain View, CA) as described previously. TUSC2-induced H1299 and H157 cells were selected after exposure to 2 μg/mL doxycycline for 48 hours and assessed for TUSC2 expression using Western blot analysis.
+ Open protocol
+ Expand
8

Inducible Cell Lines for Lck Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable, inducible cell lines were generated using the Lenti-X Tet-On-Advanced Inducible Expression System (Clontech Laboratories, Inc) according to the manufacturer’s instructions. Briefly, JCaM1.6 were transduced with lentiviral particles (as described above) containing the PLVX-Tet-On-Advanced vector, which constitutively expresses the tetracycline-controlled transactivator rtTA-Advanced. Forty eight hours after transduction, the cells were subjected to selection by Geneticin (1 mg/ml) to generate a stable JCaM1.6-Tet-ON cell line. This parental cell line was then transduced with lentiviral particles of pLVX-Tight-Puro containing the Lck constructs and, 48 h after transduction, subjected to selection by Puromycin (10 μg/ml) and Geneticin (1 mg/ml) to generate the respective stable cell line. Expression of the Lck constructs was induced by 1 μg/ml doxycycline (dox, Sigma-Aldrich) added to the cell culture medium, routinely 14 to 18 h prior to each experiment. Potential phenotypic drift of cell cultures was reduced by conditionally expressing Lck or chimeras in JCaM1.6 by doxycycline induction for 14 to 16 h.
+ Open protocol
+ Expand
9

Inducible PDI Overexpression in VSMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVEC plated at 3 × 106 cell density were kept as above and serum-deprived for 4 h, 24 h after plating. Culture medium was replaced by fresh DMEM high glucose medium without serum and antibiotics. Plasmids (20–30 μg) or siRNAs (500–1000 nM) were diluted in transfection medium and lipofectamine according to manufacturer’s instructions (Invitrogen) and incubated with cells for 8 h, followed by change to RPMI plus 10% FBS. Cells were used 24, 48 and 72 h after transfection. b) Lentiviral-carried Tet-on system: Inducible PDI overexpression was achieved in rabbit VSMC coinfected with 2 different lentiviruses, one carrying rat PDIA1 gene (with a myc tag inserted at the C-terminus before the C-terminal KDEL sequence, a kind gift of Drs. Tomohiro Nakamura and Stuart Lipton (Burnham Institute for Medical Research, La Jolla, USA) under control of the Tet-inducible promoter/modified Tet-Responsive Element (TREmod), and the regulatory plasmid, which carries the reverse tetracycline trans-activator (rtTA), (Lenti-X Tet-On Advanced Inducible Expression System, Clontech).
+ Open protocol
+ Expand
10

Inducible Lentiviral Expression System

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviruses were produced according to the Lenti‐X Tet‐ON Advanced Inducible Expression System (Clontech). HEK293T helper cells were transfected with packaging plasmids pMd2.G and psPAX2 using Lipofectamine 2000 (Life Technologies) to generate responsive lentiviruses carrying pLVX‐Tight‐Puro, pLVX‐Tight‐Puro‐H2B‐GFP/α‐Tubulin mCherry 24, pLVX‐Tight‐Puro‐GFP‐MCAK, pLVX‐Tight‐Puro‐GFP‐Kif2b, or pLVX‐Tight‐Puro‐mEOS‐α‐Tubulin, as well as transactivator lentiviruses carrying the rtTA expressing construct (pLVX‐Tet‐On Advanced). Human fibroblasts were then co‐infected for 6 h with both the responsive and the transactivator lentiviruses (2:1 ratio) in the presence of 8 μg/ml polybrene (AL‐118, Sigma‐Aldrich). Co‐transduction was induced with 500 ng/ml doxycycline (D9891, Sigma‐Aldrich). Transfection efficiencies of all experiments were determined by scoring the number of fluorescent cells, or protein levels by Western blot analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!